A Focused Clinical Review of Lynch Syndrome

Demetra Georgiou,1 Laura Monje-Garcia,2,3 Tracie Miles,4 Kevin Monahan,2,5 Neil AJ Ryan6,7 1Genomics and Personalised Medicine Service, Charing Cross Hospital, London, UK; 2The St Mark’s Centre for Familial Intestinal Cancer Polyposis, St Mark’s Hospital, London, UK; 3School of Public Health, Imperi...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Georgiou D, Monje-Garcia L, Miles T, Monahan K, Ryan NAJ
स्वरूप: लेख
भाषा:English
प्रकाशित: Dove Medical Press 2023-01-01
श्रृंखला:Cancer Management and Research
विषय:
ऑनलाइन पहुंच:https://www.dovepress.com/a-focused-clinical-review-of-lynch-syndrome-peer-reviewed-fulltext-article-CMAR
_version_ 1828058381880918016
author Georgiou D
Monje-Garcia L
Miles T
Monahan K
Ryan NAJ
author_facet Georgiou D
Monje-Garcia L
Miles T
Monahan K
Ryan NAJ
author_sort Georgiou D
collection DOAJ
description Demetra Georgiou,1 Laura Monje-Garcia,2,3 Tracie Miles,4 Kevin Monahan,2,5 Neil AJ Ryan6,7 1Genomics and Personalised Medicine Service, Charing Cross Hospital, London, UK; 2The St Mark’s Centre for Familial Intestinal Cancer Polyposis, St Mark’s Hospital, London, UK; 3School of Public Health, Imperial College, London, UK; 4South West Genomics Medicine Service Alliance, Bristol, UK; 5Department of Gastroenterology, Imperial College, London, UK; 6Department of Gynaecological Oncology, Royal Infirmary of Edinburgh, Edinburgh, UK; 7The College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, UKCorrespondence: Neil AJ Ryan, Department of Gynaecology Oncology, Royal Infirmary of Edinburgh, Edinburgh, UK, Email neilryan@nhs.netAbstract: Lynch syndrome (LS) is an autosomal dominant condition that increases an individual’s risk of a constellation of cancers. LS is defined when an individual has inherited pathogenic variants in the mismatch repair genes. Currently, most people with LS are undiagnosed. Early detection of LS is vital as those with LS can be enrolled in cancer reduction strategies through chemoprophylaxis, risk reducing surgery and cancer surveillance. However, these interventions are often invasive and require refinement. Furthermore, not all LS associated cancers are currently amenable to surveillance. Historically only those with a strong family history suggestive of LS were offered testing; this has proved far too restrictive. New criteria for testing have recently been introduced including the universal screening for LS in associated cancers. This has increased the number of people being diagnosed with LS but has also brought about unique challenges such as when to consent for germline testing and questions over how and who should carry out the consent. The results of germline testing for LS can be complicated and the diagnostic pathway is not always clear. Furthermore, by testing only those with cancer for LS we fail to identify these individuals before they develop potentially fatal pathology. This review will outline these challenges and explore solutions. Furthermore, we consider the potential future of LS care and the related treatments and interventions which are the current focus of research.Keywords: genetic counselling, Lynch syndrome, mainstreaming
first_indexed 2024-04-10T21:26:20Z
format Article
id doaj.art-9fd2b73c17df4610b51c8f3a3623197c
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-04-10T21:26:20Z
publishDate 2023-01-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-9fd2b73c17df4610b51c8f3a3623197c2023-01-19T17:31:53ZengDove Medical PressCancer Management and Research1179-13222023-01-01Volume 15678581048A Focused Clinical Review of Lynch SyndromeGeorgiou DMonje-Garcia LMiles TMonahan KRyan NAJDemetra Georgiou,1 Laura Monje-Garcia,2,3 Tracie Miles,4 Kevin Monahan,2,5 Neil AJ Ryan6,7 1Genomics and Personalised Medicine Service, Charing Cross Hospital, London, UK; 2The St Mark’s Centre for Familial Intestinal Cancer Polyposis, St Mark’s Hospital, London, UK; 3School of Public Health, Imperial College, London, UK; 4South West Genomics Medicine Service Alliance, Bristol, UK; 5Department of Gastroenterology, Imperial College, London, UK; 6Department of Gynaecological Oncology, Royal Infirmary of Edinburgh, Edinburgh, UK; 7The College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, UKCorrespondence: Neil AJ Ryan, Department of Gynaecology Oncology, Royal Infirmary of Edinburgh, Edinburgh, UK, Email neilryan@nhs.netAbstract: Lynch syndrome (LS) is an autosomal dominant condition that increases an individual’s risk of a constellation of cancers. LS is defined when an individual has inherited pathogenic variants in the mismatch repair genes. Currently, most people with LS are undiagnosed. Early detection of LS is vital as those with LS can be enrolled in cancer reduction strategies through chemoprophylaxis, risk reducing surgery and cancer surveillance. However, these interventions are often invasive and require refinement. Furthermore, not all LS associated cancers are currently amenable to surveillance. Historically only those with a strong family history suggestive of LS were offered testing; this has proved far too restrictive. New criteria for testing have recently been introduced including the universal screening for LS in associated cancers. This has increased the number of people being diagnosed with LS but has also brought about unique challenges such as when to consent for germline testing and questions over how and who should carry out the consent. The results of germline testing for LS can be complicated and the diagnostic pathway is not always clear. Furthermore, by testing only those with cancer for LS we fail to identify these individuals before they develop potentially fatal pathology. This review will outline these challenges and explore solutions. Furthermore, we consider the potential future of LS care and the related treatments and interventions which are the current focus of research.Keywords: genetic counselling, Lynch syndrome, mainstreaminghttps://www.dovepress.com/a-focused-clinical-review-of-lynch-syndrome-peer-reviewed-fulltext-article-CMARgenetic counsellinglynch syndromemainstreaming
spellingShingle Georgiou D
Monje-Garcia L
Miles T
Monahan K
Ryan NAJ
A Focused Clinical Review of Lynch Syndrome
Cancer Management and Research
genetic counselling
lynch syndrome
mainstreaming
title A Focused Clinical Review of Lynch Syndrome
title_full A Focused Clinical Review of Lynch Syndrome
title_fullStr A Focused Clinical Review of Lynch Syndrome
title_full_unstemmed A Focused Clinical Review of Lynch Syndrome
title_short A Focused Clinical Review of Lynch Syndrome
title_sort focused clinical review of lynch syndrome
topic genetic counselling
lynch syndrome
mainstreaming
url https://www.dovepress.com/a-focused-clinical-review-of-lynch-syndrome-peer-reviewed-fulltext-article-CMAR
work_keys_str_mv AT georgioud afocusedclinicalreviewoflynchsyndrome
AT monjegarcial afocusedclinicalreviewoflynchsyndrome
AT milest afocusedclinicalreviewoflynchsyndrome
AT monahank afocusedclinicalreviewoflynchsyndrome
AT ryannaj afocusedclinicalreviewoflynchsyndrome
AT georgioud focusedclinicalreviewoflynchsyndrome
AT monjegarcial focusedclinicalreviewoflynchsyndrome
AT milest focusedclinicalreviewoflynchsyndrome
AT monahank focusedclinicalreviewoflynchsyndrome
AT ryannaj focusedclinicalreviewoflynchsyndrome